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Radiation damage inﬂicted during diffraction data collection
in macromolecular crystallography has re-emerged in the last
decade as a major experimental and computational challenge,
as even for crystals held at 100 K it can result in severe data-
quality degradation and the appearance in solved structures
of artefacts which affect biological interpretations. Here, the
observable symptoms and basic physical processes involved in
radiation damage are described and the concept of absorbed
dose as the basic metric against which to monitor the
experimentally observed changes is outlined. Investigations
into radiation damage in macromolecular crystallography are
ongoing and the number of studies is rapidly increasing. The
current literature on the subject is compiled as a resource for
the interested researcher.
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1. Introduction
The advent of highly intense wiggler and undulator beamlines
fed from synchrotron sources has reintroduced the age-old
problem of X-ray radiation damage in macromolecular crys-
tallography (MX) even for crystals held at cryogenic tempera-
tures (100 K). Unfortunately, such damage to macromolecular
crystalline samples during the experiment is a problem that
is inherent in using ionizing radiation to obtain diffraction
patterns and has presented a challenge to MX since the
beginning of the ﬁeld. For room-temperature (RT) data
collections, it often necessitates the use of many crystals to
assemble a complete data set, because the crystalline order of
the sample is damaged and decreases during the experiment
and thus the diffracted intensity fades. The root cause of this
damage is the energy lost by the beam in the crystal owing
to either the total absorption or the inelastic scattering of a
proportion of the X-rays as they pass through the crystal. The
measure of this energy loss is the ‘dose’ measured per mass of
the sample, given in SI units of grays (Gy; 1 Gy = 1 J kg
 1).
Dose may also be quoted in terms of the non-SI unit rad
(radiation absorbed dose; 1 rad = 10 mGy). In MX, dose
measurements are generally of the order of a million grays
(1 MGy or 100 Mrad).
The earliest investigation of radiation damage at RT in MX
was carried out nearly 50 years ago by Blake & Phillips (1962)
on a sealed-tube (copper) X-ray source. By making seven sets
of successive measurements, they monitored the decay in the
diffraction intensity of a particular set of reﬂections from
crystals of sperm-whale myoglobin over a period of 300 h.
They concluded that the damage was proportional to the
irradiation time, which they assumed was linearly proportional
to the absorbed dose. They deduced that a single 8 keV X-ray
photon disrupts around 70 protein molecules and disorders afurther 90 protein molecules for doses up to about 20 Mrad
(0.2 MGy) absorbed after 100 h of X-ray exposure. The
observed form of the decay with dose could be described by an
exponential function representing a ﬁrst-order process,
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where It corresponds to the measured intensity at a particular
time, I0 is the initial intensity, B is a measure of disorder,   is
the angle of diffraction and   is the incident X-ray wavelength.
According to their model, after any irradiation the crystal
consists of three components: (i) an undamaged fraction (A1)
which is entirely responsible for the remaining diffraction at
high angles, (ii) a highly disordered fraction (A2) which only
contributes to the diffraction at low angles and (iii) a thor-
oughly disorganized or amorphous part [1   (A1 + A2)=A3]
which no longer contributes to the single-crystal diffraction at
all. From their plot of A1, A2 and A3 against time derived from
the seven successive sets of measurements and using their
dose estimates it can be deduced that half of the crystal
volume became amorphous after a dose of 0.59 MGy.
Blake & Phillips (1962) also suggested that the protein
molecules suffered speciﬁc structural damage. This conclusion
was reached without knowledge of either the sequence or the
three-dimensional structure of the protein, and the postulate
was only conﬁrmed many years later when radiation damage
to disulﬁde bridges was noted in electron-density difference
maps calculated from data collected from des-pentapeptide
insulin crystals (Helliwell, 1988) as well as the opening of
aromatic side chains in maps of ribonuclease (unpublished
results from Burley and coworkers referred to in Helliwell,
1988). As early as 1958, it was postulated that covalent bonds
in proteins provided a migratory route for ionizing energy
from absorbed incident radiation to break weaker bonds
(Augenstein, 1958). Breakage of disulﬁde bonds had been
reported following the irradiation of solutions of the proteins
trypsinogen and chymotryspinogen by 186 keV electrons
(produced by the decay of the radionuclide
35S; Peche `re et al.,
1958). The presence of sulfur radicals and the subsequent
formation of —SH groups was conﬁrmed by ESR measure-
ments (Gordy & Shields, 1958).
Following the work of Blake & Phillips (1962), various
researchers (Hendrickson et al., 1973; Hendrickson, 1976;
Fletterick et al., 1976) investigated the radiation-damage
problem in protein crystals both theoretically and experi-
mentally at RT and made modiﬁcations to the initial model
presented above. A detailed description of these develop-
ments can be found in the literature (Southworth-Davies et al.,
2007) and will not be repeated here. The resulting working
model for RT damage which ﬁtted all the available data was
that there appeared to be no direct pathway between states A1
and A3 and thus the rate constant for transition from un-
damaged to amorphous was zero. Additionally, it was found
necessary to include an intermediate dose-dependent stage
labelled A1
0 between the undamaged and the damaged stages
as shown in (2). This state conformationally resembled the
undamaged state and thus still contributed to diffraction at all
angles (Sygusch & Allaire, 1988),
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Up until the 1990s, MX data were almost exclusively collected
at RT, where the recommended practice was to monitor the
intensity I0 of a strong reﬂection as the experiment proceeded
and to discard the crystal once the intensity had dropped to
0.85I0, or at the very worst 0.70I0 if the particular crystals were
in very short supply (Blundell & Johnson, 1976).
Much earlier, improved resolution of diffraction had been
observed for crystals held at 246 K (King, 1958), although at
the time this was not understood in terms of reduced radiation
damage. Systematic measurements comparing the decay of
two particular reﬂections for crystals held at 198 and 298 K
(Haas & Rossmann, 1970) and efforts to import small-
molecule crystallography cooling techniques into MX (Hope,
1988) showed that this would be an effective radiation-damage
mitigation strategy. By irradiating the crystal while holding it
at a reduced temperature, its lifetime should be signiﬁcantly
improved, since many of the radical species produced by the
energy loss of the beam would diffuse much more slowly or
not at all and would thus not further interact, so reducing the
collateral damage.
The cryocooling technique blossomed and was made tech-
nically more accessible for routine use in MX because of
two pivotal developments: the loop-mounting method (Teng,
1990), in which the protein crystal is held by surface tension in
a ﬁlm of liquid ‘cryo-buffer’ across a small-diameter (1 mm
down to 0.1 mm) nylon or ﬁbre loop, and the availability
of a reliable open-ﬂow unpressurized cryostat with ﬂexible
stainless-steel hosing (Cosier & Glazer, 1986) to supply a
stream of cooled gaseous nitrogen at a stable temperature of
around 100 K with which to surround the sample during data
collection. Initially, problems with the technique included ice
formation within and outside the crystal and an increase in
mosaic spread, particularly when cryocooling protocols were
not optimized. Methods for improving the data quality
obtainable were soon developed (Rodgers, 1997; Garman &
Schneider, 1997; Garman, 1999; Pﬂugrath, 2004; Garman &
Owen, 2006) and there was widespread adoption of the
technique. In fact it has been estimated that over 90% of all
protein structures are now determined at cryo-temperatures
(Garman, 2009).
The advantages of cryocooling for MX are a reduction in
the rate of radiation damage; the use of a mounting technique
(the loop) that is usually more gentle than the capillary
method historically used for RT collection; the fact that higher
resolution data can more easily be obtained because the
crystal order is preserved for longer; a lower background in
the diffraction experiment as it is not necessary to enclose the
crystal in a glass, quartz or plastic tube to prevent dehydration;
that fewer crystals (and thus a lower quantity of protein) are
required for a project; that crystals can be shipped ahead of
time to the synchrotron (more or less) safely; and that crystals
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before they start to degrade in the crystallization drop.
These positive aspects of cryocooling commonly outweigh
the disadvantages. The latter include the requirement for
expensive cryostat cooling equipment, a frequent increase in
crystal mosaic spread (but not necessarily if the cryoprotection
concentration and crystal handling are carefully optimized),
the need to invest time for optimization of cryo-buffers and
cooling protocols, and the fact that there are as yet no
protocols that guarantee success, although progress is being
made in this direction (see, for example, Alcorn & Juers,
2010).
The improvement in dose tolerance for a crystal held at
100 K compared with a crystal irradiated at RT has been
estimated to be approximately a factor of 70 on average (Nave
& Garman, 2005). Thus, cryocooling is clearly a highly effec-
tive mitigation strategy. However, radiation damage is now
routinely observed at synchrotrons in cryocooled crystals and
the experimenter would be wise to be aware of the artefacts
that can be produced. Below, the symptoms of radiation
damage at cryotemperatures and the basic physical processes
involved are described, the reasons why the crystallographer
should care about this issue are addressed, and our current
knowledge, as reﬂected in the published literature, is collated.
The interested reader is also referred to Garman & Owen
(2006) and Ravelli & Garman (2006), and to a recent article
entitled A beginner’s guide to radiation damage (Holton,
2009).
2. What are the symptoms of radiation damage at
cryotemperatures?
Systematic studies of this phenomenon have identiﬁed two
separate indicators of damage as a function of dose: global
research papers
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Figure 1
Global radiation-damage indicators as a function of dose for four holoferritin crystals (Owen et al., 2006). (a) Mean I/mean I0,( b) unit-cell volume, (c) R
value and (d) Wilson B value.(Fig. 1) and speciﬁc (Fig. 2) damage. The former results in a
loss of the measured reﬂection intensities (particularly at high
resolution), expansion of the unit-cell volume, increasing
values of the measure of the internal consistency of the data
which quantiﬁes the difference between reﬂection intensities
that should ideally be the same (Rmeas), an increase in both the
scaling B factors for the data and the atomic B values of the
reﬁned structure, rotation of the molecule within the unit cell
and often (but not always) an increase in mosaicity. Visible
differences in the samples as the experiment proceeds,
including colour changes, are also observed. On warming of
the sample following irradiation, bubbles of gas, now proposed
to be hydrogen (Meents et al., 2009, 2010) and perhaps some
CO2, are emitted and discolouration of the sample is common
(see Fig. 3).
Various metrics have been suggested and used for moni-
toring global damage, among which are the following.
(i) ID/I1, where ID is the summed mean intensity (Imean)o fa
complete data set (or equivalent sections of data) after a dose
D and I1 is the mean intensity of the ﬁrst data set. Note that
using ID/ D (where  D is the standard deviation of the signal,
i.e. the ‘noise’) normalized to the intensity I1/ 1 of the ﬁrst
data set is not a robust metric since the noise  D increases with
dose and thus ID/ D reduces by an amount that more than
represents the true loss of diffracting power.
(ii) Rd, the pairwise R factor between identical and
symmetry-related reﬂections occurring on different diffraction
images, plotted against the difference in dose, D, between
the images on which the reﬂections were collected (Dieder-
ichs, 2006). The plot of Rd against D is a straight line parallel
to the x axis if there is no damage, but rises linearly in the
presence of damage (see Fig. 4). This plot can be used to
correct the intensity values of the reﬂections back to their
‘zero-dose’ values to improve the data quality (Diederichs et
al., 2003).
(iii) The isotropic B factor (Brel) has been found to be a
robust measure of radiation damage at 100 K and to be line-
arly dependent on it (Kmetko et al., 2006). An example of Brel
plotted against dose is given in Fig. 5. The relative B factors
can be interpreted as proportional to the change in the mean-
squared atomic displacements. A coefﬁcient of sensitivity to
absorbed dose, SAD, was also deﬁned, SAD = Brel/D8 
2,
where Brel/8 
2 is the change in relative isotropic B factor
and D is the change in dose as above, i.e. SAD is the slope of
the line in a graph such as that shown in Fig. 5. This metric
relates the increase in mean-squared atomic displacements to
the dose and it has been postulated that it is similar within
research papers
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Figure 2
Speciﬁc structural damage inﬂicted on a cryocooled crystal of apoferritin
during sequential data sets collected on beamline ID14-4 at ESRF. (a)
2Fo   Fc map of Glu63 contoured at 0.2 e A ˚  3 after a dose of 2.5 MGy
and (b) after 50 MGy. (c)2 Fo   Fc map of Met96 contoured at 0.2 e A ˚  3
after a dose of 2.5 MGy and (d) after 50 MGy, showing loss of electron
density around the disordered atoms (Garman & Owen, 2006).
Figure 3
Photograph of a 400 mm neuraminidase crystal (subtype N9 from avian
inﬂuenza isolated from a noddy tern), space group I432, that has been
irradiated on ID14-4 at the ESRFat 100 K and then allowed to warm up
to RT. The three black marks are from the 100   100 mm beam; the
discolouration is an indication of radiation damage.
Figure 4
An idealized plot of Rd, the pairwise R factor between identical and
symmetry-related reﬂections occurring on different diffraction images,
plotted against the difference in dose, D, between the images on which
the reﬂections were collected (Diederichs, 2006). The plot isa straight line
parallel to the x axis if there is no damage, but rises linearly in the
presence of damage.quite a narrow range of values for most protein crystals
(Kmetko et al., 2006).
(iv) The volume of the unit cell increases more or less
linearly with dose and was originally thought to be a possible
metric for judging the extent of radiation damage; however,
systematic work (Murray & Garman, 2002; Ravelli et al., 2002)
has shown that it is not a reliable indicator since crystals of the
same size and type expand at different rates with increasing
absorbed dose.
(v) Although mosaicity commonly increases with dose, it is
not a reliable metric for quantization of radiation damage,
since it does not behave in a reproducible or predictable
manner.
Of more direct relevance to the biological interpretation of
structures than the global indicators detailed above is the fact
that speciﬁc structural damage to particular covalent bonds is
observed to occur in a reproducible order in many proteins
(Weik et al., 2000; Burmeister, 2000; Ravelli & McSweeney,
2000): ﬁrst disulﬁde bridges elongate and then break (Weik et
al., 2002), then glutamates and aspartates are decarboxylated,
tyrosine residues lose their hydroxyl group and subsequently
the carbon–sulfur bonds in methionines are cleaved. Such
damage is illustrated in Fig. 2, which shows damage to gluta-
mate and methionine residues in a cryocooled crystal of
apoferritin during sequential data sets collected on beamline
ID14-4 at the ESRF. Covalent bonds to heavier atoms such as
C—Br, C—I and S—Hg are also ruptured (see, for example,
Ramagopal et al., 2005).
Clearly, it is not feasible to monitor the speciﬁc structural
damage during the experiment, since the reﬁned structures are
required. However, it is known that this damage often occurs
well before there is any obvious degradation of the diffraction
pattern.
The global effects of radiation damage at 100 K are thought




 2; Sliz et al., 2003).
Another study concurred with this ﬁnding but, following an
analysis of electron-density difference maps, indicated that
there might be a second-order dose-rate
effect since speciﬁc damage was slightly
more severe at higher dose rates (Leiros
et al., 2006). Conversely, however, Owen
et al. (2006) reported a small (10%)
reduction in D1/2 (the dose required to
halve the original diffraction intensity)
for a dose-rate increase from 4   10
3 to
40   10
3 Gy s
 1 at ﬂux densities of 4  
10





The manifestations of radiation
damage in the diffraction experiment
can now be monitored over a range of
time scales and doses (illustrated in Fig.
6). For instance, the formation of the
disulﬁde-anion radical, RSSR  , can be
observed in real time using UV/UV–vis
microspectrophotometry after a few
tens of milliseconds of X-ray irradiation
as a 400 nm absorption peak, and
solvated electrons have a maximal
absorbance at 550–600 nm (McGeehan
et al., 2009). This speciﬁc structural
damage is often apparent in electron-
density maps calculated using the
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Figure 6
Illustration of radiation damage over a wide range of time scales and dose. Left, UV–vis absorption
spectrum (blue, lowest; red, highest) of a cryocooled solution ofcysteine, showing an intense peak at
400 nm corresponding to disulﬁde-anion radical production. The vertical bands arise from 1 s X-ray
irradiations followed by 5–8 s of beam off, during which the 400 nm peak decays away (Southworth-
Davies & Garman, 2007). Centre, Fo   Fc difference density map (contoured at  2.5 )o ft h e
Cys76–Cys94 bond in a HEWL structure calculated using the sixth data set in a sequential collection
from one crystal (Murray & Garman, 2002). The bond is broken and the S atoms are delocalized.
Right, decay of the normalized diffraction intensity of sequential data sets collected from four
different holoferritin crystals (Owen et al., 2006). Figure modiﬁed from Owen, Pearson et al. (2009).
Figure 5
A plot of Brel (one value per data set collected on ID14-4 at the ESRF)
against dose for two HEWL crystals, one native and the other co-
crystallized with the scavengers ascorbate (Asc) and 1,4-benzoquinone
(Quin). The solid lines represent linear ﬁts to the data: the increase in Brel
is only marginally slower with dose for the scavenger cocrystals, showing
(when combined with an analysis of the resulting electron-density maps)
that this particular combination is not effective in reducing the rate of
damage (Southworth-Davies, 2008).structure factors of a data set that took around 30 s to collect
and the resulting structure represents a time and space
average over the 30 s of irradiation and over all the molecules
in the crystal (Fig. 6). Metal centres are also reduced very
swiftly by the X-ray beam and increasingly this can be moni-
tored on-line during the X-ray experiment (see, for example,
Hough et al., 2008). The global intensity loss owing to radia-
tion damage is clearly evident following the collection of
several data sets in succession from the same crystal when the
summed intensityfor each data set is plotted normalized to the
intensity of the ﬁrst data set (Fig. 6, right).
3. What is it?
Radiation damage to the sample is a result of it absorbing
photons from the beam by either the photoelectric effect
(total absorption of the photon and ejection of an inner shell
electron) or Compton scattering (inelastic scattering of the
photon, which then escapes following a varying amount of
energy loss to an atomic electron, which can also be ejected).
At the incident energies used for MX, the former effect has
a much higher cross-section and dominates the absorption,
accounting for over 90% of the energy deposited by the beam.
Each photoelectron has enough energy to subsequently
induce up to  500 further ionization events, which in turn can
result in the formation of radical species in the crystal. In
protein crystals, the presence of anything between 20% and
80% solvent means that the radiolysis of water and other
components of the solvent is an important contributor to the
creation of these species. Some of the energy deposited by
the beam during these processes is converted into heat and
induces a temperature rise in the sample. The diffracted
photons are scattered elastically and thus do not contribute to
the damage. These processes are illustrated diagrammatically
in Figs. 7(a), 7(b)a n d7 ( c). It is worth noting that for a 100 mm
thick protein crystal only 2% of the incident photons of a
12.4 keV (1 A ˚ ) X-ray beam will interact in any way with it
[ 1.7% (i.e. 84% of interacting photons) by the photoelectric
effect and  0.15% (8%) by the Compton effect, with only
 0.15% (8%) actually diffracting].
The usage of the terms ‘primary’, ‘secondary’ and ‘tertiary’
damage has become somewhat inconsistent in the literature
and is largely a matter of semantics, but the deﬁnitions that
will be adopted here are as follows.
(i) Primary damage is the ionization of an atom owing to
photoelectric absorption or Compton scattering. The primary
photoelectron has a mean track length of a few micrometres
(for 12 keV photons; O’Neill et al., 2002).
(ii) Secondary damage is that arising from the formation
of up to 500 low-energy secondary electrons per primary
absorption event, which are able to diffuse and induce further
ionization and excitation events (e.g. electronic and vibra-
tional). The secondary electrons gradually become therma-
lized (that is, they have the distribution of energies expected
at the equilibrium temperature of the sample) and chemical
reactions between the radiation-induced moieties and the
crystal components then become important.
(iii) Tertiary damage is deﬁned as the effect on the crystal
lattice and other mechanical consequences of the energy
deposition in the crystal.
Damage can also be classiﬁed as direct, if the primary
absorption event occurs at an atom in the protein molecule,
or indirect, if the radiation is absorbed by the surrounding
solvent and the reactive species formed subsequently interact
with the protein. Energy deposition in the water in and around
the crystal results in a cascade of reactions as shown below
(Ward, 1988), giving hydroxyl radicals, hydrated electrons and
H atoms, the relative amounts of which depend on the
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As described in x2 above, the knock-on effects of the energy
absorbed by the crystal manifest themselves as both a reduc-
tion of crystalline order (global damage) and speciﬁc struc-
tural damage, and over the last 10 years MX researchers have
sought to identify mechanisms that explain these observations.
At RT the products have thermal energy and can diffuse
through the crystal, causing more secondary damage as they
go. However, at cryotemperatures below 110 K nearly all the
radical species, including  OH radicals (Mike Sevilla, private
communication), are immobilized, with the notable exception
of electrons. These can quantum-mechanically tunnel along
the amino-acid backbone and have been shown by ESR
measurements to be mobile at 77 K (Jones et al., 1987). They
migrate and seek out the most electron-afﬁnic sites in the
protein which, if there are no bound metals, are the disulﬁde
bonds. This phenomenon accounts for the ‘pecking order’ of
amino acids susceptible to speciﬁc structural damage. This
mechanism also explains why the observed damage does not
occur in the order of the largest to smallest X-ray absorption
cross-sections of the atoms, as would be expected if there
were no mobile species. Away from absorption edges, X-ray
absorption cross-sections rise swiftly with the atomic number
of an atom, so if the speciﬁc structural damage arose from
primary processes alone the C—S bond in methionine should
be the second most susceptible bond (afterthe disulﬁde bond).
The reason for the global damage to crystalline order
observed in MX was until recently thought to be the conse-
quence of direct damage to the protein molecules. However,
new results show that the loss of diffractive power may instead
be attributable to the production of hydrogen gas in the
crystal. At 100 K it is likely that the hydrogen gathers
at interfaces between crystal domains, which would account
for the commonly observed increase in mosaicity with dose.
However, at 50 K it has been found that the rate of the speciﬁc
structural damage with dose was reduced by a factor of four,
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100 K. It is thus more likely that rather than collecting at
grain boundaries the hydrogen is trapped within the unit cell
at 50 K, accounting for the larger unit-cell increase at this
temperature (Meents et al., 2010).
An important experimental consideration is that at cryo-
temperatures the damage does not usually spread along the
crystal. The crystal can thus be translated with respect to the
beam so that fresh undamaged crystal can be irradiated at
multiple positions. The exception is when heavy-atom clusters
are present. The high absorption of these atoms can result in
local heating of the crystal above 110 K, at which diffusion of
 OH radicals becomes more probable (e.g. for Na
+,K
+-ATPase
crystals soaked with Ta6Br12
2+; Poul Nissen and J. Preben
Morth, private communication at the Petra-III Workshop
2007). In this case, translation of the crystal to a new position
can be unsuccessful as a strategy for obtaining more data,
since the damage can spread several tens of micrometres along
the crystal from the irradiated position.
With the advent of X-ray microbeams, the question arises as
to how close sequential irradiations can be made while
ensuring that ‘fresh’ material is in the beam, and there is
ongoing systematic research to investigate this (Robert
Fischetti, private communication).
4. Why should we care?
Radiation damage in MX is an increasingly important and
limiting problem for several reasons. Firstly, as the diffraction
experiment proceeds, creeping non-isomorphism occurs on
three simultaneous fronts: the unit-cell volume increases,
there is often movement of the protein molecule within the
unit cell, and structural changes are induced by the damage,
so that the protein conformation is changing during the
measurements. This non-isomorphism is thought to be a major
cause of unsuccessful MAD (multiple-wavelength anomalous
dispersion) structure determinations, since by the time the
second or third wavelength is collected, the cell and atomic
structure can have changed such that the reﬂection intensities
are signiﬁcantly altered. This effect can obscure the anom-
alous signal required for structure solution. It has been
calculated that a 0.5% change in all three dimensions of a
100 A ˚ 3 unit cell would change the intensity of a 3 A ˚ reﬂection
by 15% (Crick & Magdoff, 1956) so the MAD/SAD phasing
signals would be completely destroyed. An empirical rule of
thumb for successful MIR phasing has been proposed for the
absolute shift in unit-cell dimensions (X) that can be tolerated
as a function of the resolution limit of the data set (dmin):
X = dmin/4 (Drenth, 1999).
Secondly, the radiation-sensitivity of some crystals at 100 K
means that it is not possible to collect a complete data set from
a single crystal and data must be merged from several (or
many) of them to measure all the unique reﬂection intensities.
Although this was routinely the case when data were collected
at RT, most crystallographers have become accustomed to
being able to measure all unique reﬂections from just one
cryocooled crystal. Use of multiple crystals to assemble a
complete data set in general increases the errors arising from
non-isomorphism, thereby potentially reducing the ease of
structure solution as well as increasing the mounting/
dismounting time burden. Even using a robot for this opera-
tion can be slow and in fact is sometimes the most time-
consuming part of the experiment. It can also present some
pitfalls during processing. For instance, space group I4 can be
indexed with the b axis pointing in either direction, so that
when data are merged care must be taken that each section is
indexed in the same convention.
Finally, the radiation-damage-induced structural changes
can affect the apparent biological properties of the macro-
molecule under study. Enzyme mechanisms can involve redox-
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Figure 7
Primary X-ray interaction processes with the atoms of the crystal and
solvent. (a) Elastic (Thomson, coherent) scattering. The waves are phase-
shifted by 180  on scattering and add vectorially to give the diffraction
pattern. (b) Compton (incoherent) scattering. The X-ray transfers some
energy to an atomic electron and thus has lower energy (higher
wavelength) after the interaction. Energy is lost in the crystal, con-
tributing to the absorbed dose. (c) Photoelectric absorption. The X-ray
transfers allits energy toan atomic electron, which isthen ejected and can
give rise to the ionization of up to 500 other atoms. The excited atom can
then emit a characteristic X-ray or an Auger electron to return to its
ground state.susceptible residues, so special care is required when inter-
preting structures that may have been modiﬁed by X-ray
damage during the data collection. For instance, irradiation
can change the oxidation state of metal ions in structural/
active sites from that in their native state (Carugo & Djinovic
Carugo, 2005; Yano et al., 2005) and cause the decarboxylation
of glutamate and aspartate residues. X-ray-induced structural
changes can also be misleading in studies of intermediates (e.g.
Takeda et al., 2004). In such circumstances, separating radia-
tion damage from an enzymatic mechanism can be extremely
difﬁcult and can cast doubt on the validity of biological
conclusions drawn from crystal structures (Ravelli & Garman,
2006).
In summary, radiation damage ultimately results in lower
resolution structures, failed MAD structure solutions and
sometimes the inaccurate interpretation of biological results
if no control experiments are carried out to account for
radiation-damage artefacts. It is thus an issue to be taken
seriously by the structural biologist.
5. What is ‘dose’ and the ‘dose limit’?
As already stated, the universal metric against which the decay
indicators of a crystal are conveniently measured is the
absorbed dose, which is deﬁned as the energy absorbed per
unit massof the sample (Gy = J kg
 1) in the irradiated volume.
The fact that the amount of damage at 100 K is indeed
proportional to the absorption coefﬁcient and thus to the dose
has been shown in elegant experiments by Kmetko et al.
(2006) on lysozyme crystals soaked in a range of concentra-
tions of various heavy-atom solutions.
The ‘dose postulate’states that there exists a universal ‘dose
limit’, which is the maximum energy/mass that a macro-
molecular crystalline sample can tolerate before the diffrac-
tion will fade to a given level (traditionally half) of its original
intensity. A crystal might not survive until the limit is reached
(e.g. if there were susceptible residues at crystal contacts;
Murray et al., 2005), but it would not be expected to survive
beyond it. From observations made of the dose which gener-
ally caused biological samples at 77 K to lose half of their
diffracting power (D1/2) during two-dimensional diffraction
experiments in electron microscopy, Henderson (1990) esti-
mated a ‘dose limit’ (known as the ‘Henderson limit’) for
three-dimensional macromolecular X-ray crystallography of
20 MGy. This was later measured experimentally in a series
of experiments on apoferritin and holoferritin crystals (see
Fig. 6), the absorption coefﬁcients of which differ by a factor
of two (Owen et al., 2006). The composition of the crystals
was determined using proton-induced X-ray emission (PIXE;
Garman & Grime, 2005) in order to obtain as accurate values
as possible of, in particular, the iron content. This minimized
the errors in the dose calculations. The dose limit (D1/2) was
found to be 43 MGy, although the recommended maximum
dose was only 30 MGy in order to avoid compromising the
biological information extracted from deduced structures. This
dose limit corresponded to a drop in diffraction intensity to
70% (D0.7) of the initial value (Owen et al., 2006). A number
of other studies have corroborated this dose limit. An analysis
of all the various experimental measurements has been made
by Howells et al. (2009), who concluded that the resolution-
dependent D1/2 was 10d MGy (where d is the resolution in A ˚ :
thus for a 2 A ˚ reﬂection D1/2 = 20 MGy). This issue is
described in detail later in this volume (Holton & Frankel,
2010). As noted above, this limit is thought to be largely
independent of dose rate at cryotemperatures at the ﬂux
densities currently used in MX. It is also worth reiterating that
structural damage generally occurs well before visible degra-
dation of the diffraction pattern is observed. Thus, it is in-
advisable to plan an experiment which requires collecting data
beyond the time when the dose limit (which was determined
from intensity decay) is reached.
In the RT model developed by Blake & Phillips (1962),
damage is directly proportional to dose and no dose-rate
effect is included. Despite anecdotal reports from the early
days of synchrotron use with crystals irradiated at RT that
they had longer lifetimes at higher dose rates, this was only
systematically investigated recently, when an inverse dose-rate
effect was measured in-house at RT between dose rates of 6
and 10 Gy s
 1, the higher rate giving four times the dose
tolerance (i.e. four times the dose required to halve the total
diffraction intensity, D1/2) for hen egg-white lysozyme crystals
(Southworth-Davies et al., 2007). For irradiation at a dose rate
of 2800 Gy s
 1 at a synchrotron at RT, ten times the dose
tolerance has been recorded (Barker et al., 2009). The expla-
nation of this phenomenon is that at high dose rates radicals
produced in the crystal neutralize one another and thus do not
cause further damage, whereas at lower dose rates they travel
further, interacting with protein and solvent to produce
additional damage.
Interestingly, the RTexponential intensity decay with dose,
which is typical of a ﬁrst-order process (where the decay rate
depends on the amount of material left), can be modiﬁed by
the addition of scavenger molecules to become a zeroth-order
dependence (where the rate of decay is a constant). This effect
is not yet completely understood. At RT, the dose tolerance of
HEWL crystals (as measured by the change in D1/2) has been
shown to be improved by factors of  2 and  9 by the addition
of the scavengers ascorbate and 1,4-benzoquinone, respec-
tively (Barker et al., 2009).
To calculate the available time in the beam before the
crystal reaches the experimental dose limit, knowledge of the
sample size and composition (i.e. the number of each atom
type in the unit cell) is required so that absorption coefﬁcients
can be computed, as well as detailed information about the
incident beam [energy, size, shape and ﬂux (in photons s
 1)].
For MX, this can be conveniently carried out by means of
the program RADDOSE (Murray et al., 2004; Paithankar et
al., 2009; Paithankar & Garman, 2010), version 3 of which
includes both the probability of ﬂuorescent X-ray escape
(non-negligible for heavy-atom-containing crystals) and the
energy loss owing to Compton scattering (non-negligible
above 20 keV). The calculations rely on accurate ﬂux
measurements being available for the X-ray beam at the
particular beamline being used (Owen, Holton et al., 2009).
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crystals larger than the beam size where a fresh unirradiated
crystal is continually being rotated into the beam. The time
before the experimental limit is reached is thus under-
estimated in these cases. Currently, developments are under
way that aim to provide on-line digitization of both the crystal
shape and its position relative to the rotation axis of the
goniometer. These efforts are being largely driven by the need
for improved absorption corrections, but when the crystal
information can be incorporated into RADDOSE they
research papers
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Table 1
Compendium of the current literature on MX radiation damage.
Every effort has been made to make this compilation exhaustive: a copy is maintained and updated at the URL http://www.biop.ox.ac.uk/www/garman/
gindex.html. References to the pre-1990 papers on RT MX damage studies can be found in x1.
Crystal-related questions
What is the minimum crystal size? Gonzalez & Nave (1994), Teng & Moffat (2000), Glaeser et al. (2000), Sliz et
al. (2003), Nave & Hill (2005), Cowan & Nave (2008), Moukhametzianov et
al. (2008), Holton (2009), Holton & Frankel (2010)
What affects X-ray absorption? (and RADDOSE) Murray et al. (2004, 2005), Kmetko et al. (2006), Holton (2007, 2009),
Paithankar et al. (2009), Paithankar & Garman (2010)
Can the unit-cell expansion be used as a metric? Teng & Moffat (2000), Murray & Garman (2002), Ravelli et al. (2002), Mu ¨ller
et al. (2002)
What is the effect of temperature (e.g. 100, 16, 40 K)? Garman (1999), Hanson et al. (1999, 2002), Weik et al. (2001), Teng & Moffat
(2002), Yano et al. (2005), Grablolle et al. (2006), Borek et al. (2007),
Meents et al. (2007, 2010), Chinte et al. (2007), Corbett et al. (2007),
Colletier et al. (2008)
Does the addition of radical scavengers increase dose tolerance? Murray & Garman (2002), Betts (2004), Kauffmann et al. (2006), Borek et al.
(2007), Southworth-Davies & Garman (2007), Holton (2007), Macedo et al.
(2009), Barker et al. (2009), Nowak et al. (2009)
What are the susceptibilities of particular amino acids to speciﬁc damage
and why?
Weik et al. (2000), Ravelli & McSweeney (2000), Burmeister (2000), Leiros et
al. (2001), Fioravanti et al. (2007)
X-ray beam-related questions
What is the effect of changing the incident wavelength? Arndt (1984), Gonzalez & Nave (1994), Murray et al. (2004), Weiss et al.
(2005), Shimizu et al. (2007)
Is it beneﬁcial to change/regulate the dose/dose-rate regime? Teng & Moffat (2000), O’Neill et al. (2002), Sliz et al. (2003), Ravelli et al.
(2002), Leiros et al. (2006), Owen et al. (2006), Howells et al. (2009)
What is the effect of the beam size compared with the crystal size? Schulze-Briese et al. (2005)
Does the beam heat the crystal? Kuzay et al. (2001), Nicholson et al. (2001), Mu ¨ller et al. (2002), Snell et al.
(2002, 2005, 2007), Kriminski et al. (2003), Mhaisekar et al. (2005)
Methods developments and applications
Development of convenient ﬂux calibration of beamlines Owen et al. (2009)
Development of on-line and off-line spectroscopy (UV–vis, Raman, XAS,
EPR)
Weik et al. (2002), Murray & Garman(2002), Matsuiet al. (2002), Takeda et al.
(2004), Sato et al. (2004), Adam et al. (2004, 2009), Yano et al. (2005),
Dubnovitsky et al. (2005), Carpentier et al. (2007), McGeehan et al. (2007,
2009), Pearson et al. (2007), Corbett et al. (2007), Holton (2007), Hough et
al. (2008), Utschig et al. (2008), Owen et al. (2009)
Studying the effect on the success of MAD/SAD phasing Rice et al. (2000), Schiltz et al. (2004), Zwart et al. (2004), Gonza ´lez et al.
(2005), Gonza ´lez (2007), Ramagopal et al. (2005), Ravelli et al. (2005),
Olie ´ric et al. (2007)
Development of RIP/RIPAS Ravelli et al. (2003, 2005), Banumathi et al. (2004), Weiss et al. (2004), Nanao
et al. (2005), Nanao & Ravelli (2006), Schiltz & Bricogne (2007), Rudin ˜o-
Pin ˜era et al. (2007), Fu ¨tterer et al. (2008), Scho ¨nfeld et al. (2008)
Application/effect of radiation damage to/on the study of biological
mechanisms
Matsui et al. (2002), Alphey et al. (2003), Nukaga et al. (2003), Mees et al.
(2004), Takeda et al. (2004), Kort et al. (2004), Roberts et al. (2005),
Dubnovitsky et al. (2005), Sjo ¨blom et al. (2009), Adam et al. (2009)
Metalloproteins Schlichting et al. (2000), Berglund et al. (2002), Adam et al. (2004), Baxter et
al. (2004), Sato et al. (2004), Carugo & Djinovic Carugo (2005), Yano et al.
(2005), Echalier et al. (2006), Pearson et al. (2007), Beitlich et al. (2007),
Ku ¨hnel et al. (2007), Corbett et al. (2007), Hough et al. (2008), Petrova et al.
(2009)
Phase transitions and/or radiation-induced changes with temperature-
controlled cryocrystallography to study macromolecular function
Schlichting et al. (2000), Weik, Kryger et al. (2001), Weik, Ravelli et al. (2001),
Weik et al. (2005), Hersleth et al. (2008), Colletier et al. (2008)
Software developments Diederichs et al. (2003), Nanao et al. (2005), Bourenkov & Popov (2006, 2010),
Diederichs (2006), Schiltz & Bricogne (2007)
Finding strategies to minimize radiation damage in data collections Berglund et al. (2002), Adam et al. (2004), Stern et al. (2009), Incardona et al.
(2009), Borek et al. (2010)
Extending the understanding of radiation damage in RT data collections Southworth-Davies et al. (2007), Barker et al. (2009)
Studying RNA/DNA damage Ennifar et al. (2002), Mees et al. (2004), Schiltz et al. (2004), Olie ´ric et al.
(2007), McGeehan et al. (2007)should also make possible the further improvement of dose
estimates.
6. What do we know and what would we like to know?
There are many parameters that can be varied in an MX
experiment, some of which can affect the rate of radiation
damage to (or ‘dose tolerance’ of) a crystal. There are two
challenges for researchers seeking to understand and trying to
mitigate radiation damage. The ﬁrst is to truly isolate the
variable to be tested and to only change one experimental
condition at a time so that deﬁnite conclusions can be reached.
The second is to use a reliable metric(s) of radiation damage
so that the effect of protocol modiﬁcations can be properly
assessed. In addition, to reach a statistically signiﬁcant result
the same experiments must be repeated and reproduced on
several crystals of the same protein and ideally extended to
check the validity of the results in a more general way by
conducting the same tests for a number of different proteins.
Over the last 10 years there has been an extensive search
for reliable metrics of global and structurally speciﬁc radiation
damage. Since structural changes occur even before degra-
dation of diffraction quality is apparent, intensity loss cannot
be used as a yardstick with which to judge damage to speciﬁc
amino acids, which is only obvious when the electron-density
maps have been calculated once enough data have been
collected. This can be understood because the diffraction loss
occurs in reciprocal space and the speciﬁc damage in real
space, and one point in real space contributes to all reﬂections
in reciprocal space and vice versa.
The parameter space of an MX experiment is composed of
variables that can be categorized as follows (Garman, 2003).
(i) The crystal in the cryo-loop: heavy-atom content (Se,
S etc.), solvent content, solvent composition, crystal size and
surface-to-volume ratio, the amount of residual liquid around
the crystal prior to ﬂash-cooling, the choice and concentration
of cryoprotectant agent, the time spent in the cryobuffer prior
to cooling, the ﬂash-cooling method (stream or liquid), the
cryogen used to ﬂash-cool, the amount of crystal manipula-
tion, the local humidity and the speed of the experimenter
when ﬂash-cooling from the cryobuffer drop.
(ii) The X-ray beam: the ﬂux density, the energy (wave-
length), the beam size compared with the crystal size, the dose
and the dose rate.
(iii) The cryostat: the cold gas ﬂow rate, the temperature
and the cryogen (N2 or He).
Systematic experiments to address the dependence of the
rate of radiation damage on all these factors would take many
years and be very labour-intensive in terms of data collection
and processing, as well as requiring many hours of synchrotron
beamtime. However, some of these variables have been
investigated and studies can be broadly categorized as follows.
(i) Crystal related.
What is the minimum crystal size?
What affects X-ray absorption?
Can the unit-cell expansion be used as a metric?
What is the effect of temperature (e.g. 100, 16, 40 K)?
Does the addition of free-radical scavengers increase
dose tolerance?
What are the susceptibilities of particular amino acids to
speciﬁc damage and why?
(ii) X-ray beam related.
What is the effect of changing the incident wavelength?
Is it beneﬁcial to change/regulate the dose/dose-rate
regime?
What is the effect of the beam size compared with the
crystal size?
Does the beam heat the crystal?
(iii) Method developments and applications.
Development of convenient ﬂux calibration of beamlines.
Development of on-line and off-line spectroscopy (UV–
vis, Raman, XAS, EPR).
Studying the effect on the success of MAD/SAD phasing.
Development of RIP/RIPAS.
Application/effect of radiation damage to/on the study of
biological mechanisms.
Phase transitions and/or radiation-induced changes with
temperature-controlled cryocrystallography to study macro-
molecular function.
Software developments.
Finding strategies to minimize radiation damage in data
collections.
Extending the understanding of radiation damage in RT
data collections.
Studying RNA/DNA damage.
The many experiments on the above topics that have been
reportedtodatewillnotbedetailedhere,butasummaryofthe
currently available literature is presented in Table 1. Useful
collections of research papers addressing different aspects of
radiation damage in MX can be found in four special issues
of the Journal of Synchrotron Radiation, which each contain
eight or more research papers presented at the Second, Third,
Fourth and Fifth International Workshops on X-ray Radiation
Damage to Biological Crystalline Samples [Journal of
Synchrotron Radiation,V o l .9 (2002), pp. 327–381, Vol. 12
(2005), pp. 257–328, Vol. 14 (2007), pp. 1–132 and Vol. 16
(2009), pp. 129–216, respectively]. These each have a brief
introduction placing the contributions into the wider context
of research in the ﬁeld (Garman & Nave, 2002, 2009; Nave &
Garman, 2005; Garman & McSweeney, 2007).
The real question to which experimenters would like an
answer is: what can I do to obtain the largest amount of data
with the highest signal-to-noise ratio from my crystal in the
beam? The current advice would include the following: (i)
backsoaking of crystals to remove any nonspeciﬁcally bound
heavy atoms in the mother liquor (e.g. the arsenic in cacody-
late) or in a soaking solution for heavy-atom phasing, since
these heavy atoms can contribute a lot to the dose owing
to their high absorption but do not provide useful phasing
information; (ii) sacriﬁcing a crystal (if more than one crystal
of a protein exists) to obtain a data set where the aim is to
assess the radiation-sensitivity so that a suitable data-collec-
tion protocol can be designed; (iii) matching the beam size to
the crystal size; (iv) if possible using a beam with a top-hat
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portion of a Gaussian-shaped beam) so that the crystal does
not suffer differential radiation damage across its irradiated
volume; (v) using BEST to optimize the data-collection
strategy taking radiation damage into account (Bourenkov &
Popov, 2010) and (vi) being satisﬁed with a 3 A ˚ comparatively
undamaged data set for phasing rather than chasing the 2.5 A ˚
diffraction which fades as you watch and will thus be less
useful.
Above all, experimenters should make themselves aware of
the parameters known to affect the rate of radiation damage,
so that intelligent choices/compromises can be made.
7. Conclusions
Since systematic research into MX radiation damage at 100 K
began in earnest in the late 1990s, signiﬁcant progress has been
made in our knowledge and understanding of the phenom-
enon and much anecdotal evidence has been replaced by solid
experimental results. We understand better how to perform
investigations to identify suitable metrics and the importance
of routinely measuring the X-ray ﬂux so that the absorbed
dose can be calculated. The research has also prompted some
exciting new approaches such as RIP, UV-RIP/RIPAS, ‘time-
resolved’ cryocrystallography and on-line spectroscopy. How-
ever, there are still many areas where systematic investigations
are required to improve our understanding of the radiation
chemistry within an irradiated protein crystal held at either
RTor at various cryotemperatures so that better strategies for
minimizing damage can be developed.
The most useful contribution to be made by MX radiation-
damage research is in identifying concrete experimental
protocols for everyday use on synchrotron beamlines so that
researchers can ensure that they obtain the maximum possible
high-quality data from their crystals. This would ﬁrstly facil-
itate structure solution and secondly avoid compromising the
biological information extracted from the structure once
obtained.
Many collaborators and colleagues have contributed to my
ongoing education concerning the vagaries of the radiation-
damage problem and I thank them for frequent lively
discussions and debates. I am particularly grateful to Martin
Weik for vital assistance with assembling Table 1, Colin Nave
for his ever-ready penetrating questions, Adrian Lapthorn and
some unpublished parts of his 1991 PhD thesis for references
to early literature and to Ian Carmichael for constructive
comments on this manuscript. Last, but in no way least, I
applaud and greatly appreciate the members of my research
group who have willingly worked on radiation-damage
investigations during the last 10 years (James Murray, Jamie
Grimston, Enrique Rudin ˇo-Pin ˇera, Stephen Betts, Robin
Owen, Robert Southworth-Davies, Elodie Loisel, Karthik
Paithankar, Melissa Medina, Franc ¸ois-Xavier Gallat, Eliza-
beth Anscombe, Adam Barker, Azucena Jime ´nez Corona and
Eugenio de la Mora Lugo). The studies were challenging and
time-consuming, and had no ‘right answers’.
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